Unravelling the role of sphingolipids in cystic fibrosis lung disease-Reference-Cited by-同舟云学术

Unravelling the role of sphingolipids in cystic fibrosis lung disease

Published:2016-10 Issue: Volume:200 Page:94-103
ISSN:0009-3084
Container-title:Chemistry and Physics of Lipids
language:en
Short-container-title:Chemistry and Physics of Lipids

Author:

Aureli Massimo,Schiumarini Domitilla,Loberto Nicoletta,Bassi Rosaria,Tamanini Anna,Mancini Giulia,Tironi Matteo,Munari Silvia,Cabrini Giulio,Dechecchi Maria Cristina,Sonnino Sandro

Funder

Italian Cystic Fibrosis Research Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Organic Chemistry,Molecular Biology,Biochemistry

Reference89 articles.

1. Cholesterol modulates CFTR confinement in the plasma membrane of primary epithelial cells;Abu-Arish;Biophys. J.,2015

2. Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5;Adamo;Am. J. Respir. Cell Mol. Biol.,2004

3. Glycosphingolipid receptors for Pseudomonas aeruginosa;Baker;Infect. Immun.,1990

4. Acid sphingomyelinase inhibitors normalize pulmonary ceramide and inflammation in cystic fibrosis;Becker;Am. J. Respir. Cell Mol. Biol.,2010

5. Mapping the transcriptional machinery of the IL-8 gene in human bronchial epithelial cells;Bezzerri;J. Immunol.,2011

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Potential of N-Butyl-l-deoxynojirimycin (l-NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent;ACS Pharmacology & Translational Science;2024-05-10

2. Protein interactions, calcium, phosphorylation, and cholesterol modulate CFTR cluster formation on membranes;2024-05-06

3. Microbiota, metabolites and mucosal immunity as potential targets of traditional Chinese medicine for respiratory diseases based on the lung-gut crosstalk;Pharmacological Research - Modern Chinese Medicine;2024-03

4. Dual species sphingosine-1-phosphate lyase inhibitors to combine antifungal and anti-inflammatory activities in cystic fibrosis: a feasibility study;Scientific Reports;2023-12-20

5. Cross‐talk between CFTR and sphingolipids in cystic fibrosis;FEBS Open Bio;2023-06-22